{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:07:36Z","timestamp":1791896856000,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11938-006-0038-z","type":"journal-article","created":{"date-parts":[[2007,6,18]],"date-time":"2007-06-18T15:54:18Z","timestamp":1182182058000},"page":"191-200","source":"Crossref","is-referenced-by-count":5,"title":["Genetic advances in inflammatory bowel disease"],"prefix":"10.1007","volume":"9","author":[{"given":"Judy","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"38_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/379821a0","volume":"379","author":"JP Hugot","year":"1996","unstructured":"Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al.: Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome 16. Nature 1996, 379: 821\u2013823.","journal-title":"Nature"},{"key":"38_CR2","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, et al.: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278: 8869\u20138872.","journal-title":"J Biol Chem"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1074\/jbc.C200673200","volume":"278","author":"N Inohara","year":"2003","unstructured":"Inohara N, Ogura Y, Fontalba A, et al.: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn\u2019s disease. J Biol Chem 2003, 278: 5509\u20135512.","journal-title":"J Biol Chem"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0016-5085(03)00403-7","volume":"124","author":"JM Otte","year":"2003","unstructured":"Otte JM, Rosenberg IM, Podolsky DK: Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003, 124: 1866\u20131878.","journal-title":"Gastroenterology"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Inohara N, Benito A, et al.: Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001, 276: 4812\u20134818.","journal-title":"J Biol Chem"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0016-5085(03)00661-9","volume":"125","author":"S Lala","year":"2003","unstructured":"Lala S, Ogura Y, Osborne C, et al.: Crohn\u2019s disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003, 125: 47\u201357.","journal-title":"Gastroenterology"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"KS Kobayashi","year":"2005","unstructured":"Kobayashi KS, Chamaillard M, Ogura Y, et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307: 731\u2013734.","journal-title":"Science"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/hmg\/ddh182","volume":"13","author":"J Li","year":"2004","unstructured":"Li J, Moran T, Swanson E, et al.: Regulation of IL-8 and IL-1beta expression in Crohn\u2019s disease associated NOD2\/CARD15 mutations. Hum Mol Genet 2004, 13: 1715\u20131725.","journal-title":"Hum Mol Genet"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 2001, 411: 599\u2013603.","journal-title":"Nature"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 2001, 411: 603\u2013606.","journal-title":"Nature"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1086\/339432","volume":"70","author":"S Lesage","year":"2002","unstructured":"Lesage S, Zouali H, Cezard JP, et al.: CARD15\/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002, 70: 845\u2013857.","journal-title":"Am J Hum Genet"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2003.50019","volume":"124","author":"DK Bonen","year":"2003","unstructured":"Bonen DK, Ogura Y, Nicolae DL, et al.: Crohn\u2019s diseaseassociated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003, 124: 140\u2013146.","journal-title":"Gastroenterology"},{"key":"38_CR13","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1073\/pnas.0530276100","volume":"100","author":"M Chamaillard","year":"2003","unstructured":"Chamaillard M, Philpott D, Girardin SE, et al.: Geneenvironment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A 2003, 100: 3455\u20133460.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"38_CR14","doi-asserted-by":"publisher","first-page":"41701","DOI":"10.1074\/jbc.M206473200","volume":"277","author":"O Gutierrez","year":"2002","unstructured":"Gutierrez O, Pipaon C, Inohara N, et al.: Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002, 277: 41701\u201341705.","journal-title":"J Biol Chem"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/j.1572-0241.2004.40304.x","volume":"99","author":"M Economou","year":"2004","unstructured":"Economou M, Trikalinos TA, Loizou KT, et al.: Differential effects of NOD2 variants on Crohn\u2019s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004, 99: 2393\u20132404.","journal-title":"Am J Gastroenterol"},{"key":"38_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/01.MIB.0000171279.05471.21","volume":"11","author":"S Kugathasan","year":"2005","unstructured":"Kugathasan S, Loizides A, Babusukumar U, et al.: Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and white children with Crohn\u2019s disease. Inflamm Bowel Dis 2005, 11: 631\u2013638.","journal-title":"Inflamm Bowel Dis"},{"key":"38_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/gast.2002.34155","volume":"123","author":"N Inoue","year":"2002","unstructured":"Inoue N, Tamura K, Kinouchi Y, et al.: Lack of common NOD2 variants in Japanese patients with Crohn\u2019s disease. Gastroenterology 2002, 123: 86\u201391.","journal-title":"Gastroenterology"},{"key":"38_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1182\/blood-2003-10-3543","volume":"104","author":"E Holler","year":"2004","unstructured":"Holler E, Rogler G, Herfarth H, et al.: Both donor and recipient NOD2\/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004, 104: 889\u2013894.","journal-title":"Blood"},{"key":"38_CR19","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1128\/MCB.23.21.7531-7539.2003","volume":"23","author":"AL Pauleau","year":"2003","unstructured":"Pauleau AL, Murray PJ: Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003, 23: 7531\u20137539.","journal-title":"Mol Cell Biol"},{"key":"38_CR20","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1136\/gut.2003.032805","volume":"53","author":"J Wehkamp","year":"2004","unstructured":"Wehkamp J, Harder J, Weichenthal M, et al.: NOD2 (CARD15) mutations in Crohn\u2019s disease are associated with diminished mucosal alpha-defensin expression. Gut 2004, 53: 1658\u20131664.","journal-title":"Gut"},{"key":"38_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1103685","volume":"307","author":"S Maeda","year":"2005","unstructured":"Maeda S, Hsu LC, Liu H, et al.: Nod2 mutation in Crohn\u2019s disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005, 307: 734\u2013738.","journal-title":"Science"},{"key":"38_CR22","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/eji.200425229","volume":"34","author":"MG Netea","year":"2004","unstructured":"Netea MG, Kullberg BJ, de Jong DJ, et al.: NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn\u2019s disease. Eur J Immunol 2004, 34: 2052\u20132059.","journal-title":"Eur J Immunol"},{"key":"38_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1462-5822.2004.00433.x","volume":"7","author":"A Uehara","year":"2005","unstructured":"Uehara A, Yang S, Fujimoto Y, et al.: Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005, 7: 53\u201361.","journal-title":"Cell Microbiol"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni1092","volume":"5","author":"T Watanabe","year":"2004","unstructured":"Watanabe T, Kitani A, Murray PJ, Strober W: NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004, 5: 800\u2013808.","journal-title":"Nat Immunol"},{"key":"38_CR25","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1126\/science.1084677","volume":"300","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Carneiro LA, et al.: Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003, 300: 1584\u20131587.","journal-title":"Science"},{"key":"38_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/hmg\/ddi135","volume":"14","author":"DP McGovern","year":"2005","unstructured":"McGovern DP, Hysi P, Ahmad T, et al.: Association between a complex insertion\/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005, 14: 1245\u20131250.","journal-title":"Hum Mol Genet"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.gene.6364257","volume":"6","author":"S Vermeire","year":"2005","unstructured":"Vermeire S, Rutgeerts P: Current status of genetics research in inflammatory bowel disease. Genes Immun 2005, 6: 637\u2013645.","journal-title":"Genes Immun"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3748\/wjg.v11.i10.1489","volume":"11","author":"PL Lakatos","year":"2005","unstructured":"Lakatos PL, Lakatos L, Szalay F, et al.: Toll-like receptor 4 and NOD2\/CARD15 mutations in Hungarian patients with Crohn\u2019s disease: phenotype-genotype correlations. World J Gastroenterol 2005, 11: 1489\u20131495.","journal-title":"World J Gastroenterol"},{"key":"38_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/76048","volume":"25","author":"NC Arbour","year":"2000","unstructured":"Arbour NC, Lorenz E, Schutte BC, et al.: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25: 187\u2013191.","journal-title":"Nat Genet"},{"key":"38_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/JCI200420295","volume":"113","author":"MJ Lodes","year":"2004","unstructured":"Lodes MJ, Cong Y, Elson CO, et al.: Bacterial flagellin gnis a dominant antigen in Crohn disease. J Clin Invest 2004, 113: 1296\u20131306. A study demonstrating the immunodominant antigen in CD is bacterial flagellin and may drive intestinal inflammation.","journal-title":"J Clin Invest"},{"key":"38_CR31","doi-asserted-by":"crossref","unstructured":"Gewirtz AT, Vijay-Kumar M, Brant SR, et al.: Dominantnegative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn\u2019s disease. Am J Physiol Gastrointest Liver Physiol 2006, In press.","DOI":"10.1152\/ajpgi.00544.2005"},{"key":"38_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ng1001-223","volume":"29","author":"JD Rioux","year":"2001","unstructured":"Rioux JD, Daly MJ, Silverberg MS, et al.: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001, 29: 223\u2013228.","journal-title":"Nat Genet"},{"key":"38_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/376417","volume":"73","author":"C Giallourakis","year":"2003","unstructured":"Giallourakis C, Stoll M, Miller K, et al.: IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003, 73: 205\u2013211.","journal-title":"Am J Hum Genet"},{"key":"38_CR34","doi-asserted-by":"crossref","unstructured":"Waller S, Tremelling M, Bredin F, et al.: Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 2005, In press.","DOI":"10.1136\/gut.2005.084574"},{"key":"38_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ng1339","volume":"36","author":"VD Peltekova","year":"2004","unstructured":"Peltekova VD, Wintle RF, Rubin LA, et al.: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004, 36: 471\u2013475.","journal-title":"Nat Genet"},{"key":"38_CR36","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1136\/gut.52.8.1133","volume":"52","author":"A Armuzzi","year":"2003","unstructured":"Armuzzi A, Ahmad T, Ling KL, et al.: Genotype-phenotype analysis of the Crohn\u2019s disease susceptibility haplotype on chromosome 5q31. Gut 2003, 52: 1133\u20131139.","journal-title":"Gut"},{"key":"38_CR37","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2005.10.006","volume":"129","author":"S Vermeire","year":"2005","unstructured":"Vermeire S, Pierik M, Hlavaty T, et al.: Association of organic cation transporter risk haplotype with perianal penetrating Crohn\u2019s disease but not with susceptibility to IBD. Gastroenterology 2005, 129: 1845\u20131853.","journal-title":"Gastroenterology"},{"key":"38_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.gastro.2004.11.056","volume":"128","author":"B Newman","year":"2005","unstructured":"Newman B, Gu X, Wintle R, et al.: A risk haplotype in the Solute Carrier Family 22A4\/22A5 gene cluster influences phenotypic expression of Crohn\u2019s disease. Gastroenterology 2005, 128: 260\u2013269.","journal-title":"Gastroenterology"},{"key":"38_CR39","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1053\/j.gastro.2005.09.025","volume":"129","author":"CL Noble","year":"2005","unstructured":"Noble CL, Nimmo ER, Drummond H, et al.: The contribution of OCTN1\/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn\u2019s disease. Gastroenterology 2005, 129: 1854\u20131864.","journal-title":"Gastroenterology"},{"key":"38_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2036.2006.02780.x","volume":"23","author":"O Palmieri","year":"2006","unstructured":"Palmieri O, Latiano A, Valvano R, et al.: Variants of OCTN1-2 cation transporter genes are associated with both Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther 2006, 23: 497\u2013506.","journal-title":"Aliment Pharmacol Ther"},{"key":"38_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ng1345","volume":"36","author":"M Stoll","year":"2004","unstructured":"Stoll M, Corneliussen B, Costello CM, et al.: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004, 36: 476\u2013480.","journal-title":"Nat Genet"},{"key":"38_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1086\/302294","volume":"64","author":"J Hampe","year":"1999","unstructured":"Hampe J, Schreiber S, Shaw SH, et al.: A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999, 64: 808\u2013816.","journal-title":"Am J Hum Genet"},{"key":"38_CR43","doi-asserted-by":"publisher","first-page":"21709","DOI":"10.1074\/jbc.M211004200","volume":"278","author":"M Wakabayashi","year":"2003","unstructured":"Wakabayashi M, Ito T, Mitsushima M, et al.: Interaction of lp-dlg\/KIAA0583, a membrane-associated guanylate kinase family protein, with vinexin and beta-catenin at sites of cell-cell contact. J Biol Chem 2003, 278: 21709\u201321714.","journal-title":"J Biol Chem"},{"key":"38_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/humu.20301","volume":"27","author":"WG Newman","year":"2006","unstructured":"Newman WG, Gu X, Wintle RF, et al.: DLG5 variants contribute to Crohn disease risk in a Canadian population. Hum Mutat 2006, 27: 353\u2013358.","journal-title":"Hum Mutat"},{"key":"38_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/gut.45.3.395","volume":"45","author":"PC Stokkers","year":"1999","unstructured":"Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ: HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999, 45: 395\u2013401.","journal-title":"Gut"},{"key":"38_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/gast.2003.50045","volume":"124","author":"DK Bonen","year":"2003","unstructured":"Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 2003, 124: 521\u2013536.","journal-title":"Gastroenterology"},{"key":"38_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","volume":"10","author":"D Kontoyiannis","year":"1999","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, et al.: Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10: 387\u2013398.","journal-title":"Immunity"},{"key":"38_CR48","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","volume":"161","author":"CM Panwala","year":"1998","unstructured":"Panwala CM, Jones JC, Viney JL: A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998, 161: 5733\u20135744.","journal-title":"J Immunol"},{"key":"38_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2004.04.019","volume":"127","author":"T Langmann","year":"2004","unstructured":"Langmann T, Moehle C, Mauerer R, et al.: Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004, 127: 26\u201340.","journal-title":"Gastroenterology"},{"key":"38_CR50","first-page":"4761","volume":"60","author":"T Yamada","year":"2000","unstructured":"Yamada T, Takaoka AS, Naishiro Y, et al.: Transactivation of the multidrug resistance 1 gene by T-cell factor 4\/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 2000, 60: 4761\u20134766.","journal-title":"Cancer Res"},{"key":"38_CR51","doi-asserted-by":"publisher","first-page":"14581","DOI":"10.1074\/jbc.M010173200","volume":"276","author":"A Geick","year":"2001","unstructured":"Geick A, Eichelbaum M, Burk O: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001, 276: 14581\u201314587.","journal-title":"J Biol Chem"},{"key":"38_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","volume":"130","author":"MM Dring","year":"2006","unstructured":"Dring MM, Goulding CA, Trimble VI, et al.: The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease [quiz]. Gastroenterology 2006, 130: 341\u2013348. Quiz 592. oProvides further support for the concept that altered regulation of the MDR1 pathway contributes to IBD pathogenesis.","journal-title":"Gastroenterology"},{"key":"38_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2004.11.001","volume":"128","author":"K Sugawara","year":"2005","unstructured":"Sugawara K, Olson TS, Moskaluk CA, et al.: Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1\/YitFc mice and in human Crohn\u2019s disease. Gastroenterology 2005, 128: 351\u2013360.","journal-title":"Gastroenterology"},{"key":"38_CR54","first-page":"3323","volume":"96","author":"JD Lewis","year":"2001","unstructured":"Lewis JD, Lichtenstein GR, Stein RB, et al.: An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 2001, 96: 3323\u20133328.","journal-title":"Am J Gastroenterol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11938-006-0038-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0038-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T03:46:33Z","timestamp":1707968793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11938-006-0038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11938-006-0038-z","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}